Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

  • Melchiorre Cervello
    Institute of Biomedicine and Molecular Immunology, “Alberto Monroy” National Research Council (C.N.R.) Via Ugo La Malfa 153, 90146 Palermo, Italy
  • James A. McCubrey
    Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, 600 Moye Blvd, Greenville NC 27858, USA
  • Antonella Cusimano
    Institute of Biomedicine and Molecular Immunology, “Alberto Monroy” National Research Council (C.N.R.) Via Ugo La Malfa 153, 90146 Palermo, Italy
  • Nadia Lampiasi
    Institute of Biomedicine and Molecular Immunology, “Alberto Monroy” National Research Council (C.N.R.) Via Ugo La Malfa 153, 90146 Palermo, Italy
  • Antonina Azzolina
    Institute of Biomedicine and Molecular Immunology, “Alberto Monroy” National Research Council (C.N.R.) Via Ugo La Malfa 153, 90146 Palermo, Italy
  • Giuseppe Montalto
    Institute of Biomedicine and Molecular Immunology, “Alberto Monroy” National Research Council (C.N.R.) Via Ugo La Malfa 153, 90146 Palermo, Italy

収録刊行物

  • Oncotarget

    Oncotarget 3 (3), 236-260, 2012-03-31

    Impact Journals, LLC

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ